Bardia A, Rugo HS, Tolaney SM, Loirat D, et al. Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression. J Clin Oncol 2024 Feb 29:JCO2301409. doi: 10.1200/JCO.23.01409.
PMID: 38422473